From: Interstitial high-dose rate brachytherapy as boost for anal canal cancer
Data | Median | Interval |
---|---|---|
CTV (cc) | 22.3 | [8.6 - 46.7] |
D90% | 108 | [32 - 117] |
EQD2 αβ10 (Gy) | 15.1 | [5.5 - 20.6] |
EQD2 αβ3 (Gy) | 18.1 | [6.9 - 26.4] |
D100% | 77 | [20 - 95] |
EQD2 αβ10 (Gy) | 10.9 | [3.4 - 14.4] |
EQD2 αβ3 (Gy) | 13.3 | [4.3 - 18.5] |
V100 | ||
% | 96 | [58 - 100] |
cc | 18 | [8.1 - 45.8] |
V150 | ||
% | 37 | [26 - 57] |
cc | 7.2 | [2.5 - 26.6] |
V200 | ||
% | 19 | [10 - 26] |
cc | 3.4 | [1.2 - 11.7] |
DHI | 0.58 | [0.42 - 0.99] |